NCT06159439

Establishing a New Ultrasound Technique to Improve Assessment of Chronic Kidney Disease.

Validation of Contrast Enhanced Ultrasound (CEUS) for the Assessment of Renal Perfusion Using Renal Magnetic Resonance Imaging (MRI) in Chronic Kidney Disease (CKD
University of Nottingham·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Chronic Kidney Diseases
Drug/Device/Intervention
Contrast enhanced ultrasound scan
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
University of Nottingham
Timeline & enrollment
Phase
N/A
Start date
Jan 02, 2024
End date
Feb 02, 2025
Enrollment
10 participants
Primary outcome

Correlation between ASL-MRI measures of cortical perfusion (ml/ 100g/min) and CEUS measures of renal microvascular blood flow.

Summary

Blood flow to the kidneys is important in the development of kidney diseases. Currently we do
 not have ways of measuring and monitoring kidney blood flow for patients in real-time. This
 is a major barrier to investigation and management of acute kidney injury (AKI) and chronic
 kidney disease (CKD).
 
 Kidney blood flow can be reliably measured using a specialised type of MRI scan, but this is
 expensive and difficult to do in people who are unwell. Contrast-enhanced ultrasound (CEUS)
 is a new technique, which uses a contrast containing microbubbles to measure blood flow. The
 benefits of this method are that it is relatively inexpensive, the contrast agents are not
 kidney-damaging and it can be done at the bedside.
 
 We want to compare contrast enhanced ultrasound against the current best-measure of kidney
 blood flow, to see if it is giving accurate information about kidney blood flow. We will do
 this by doing both MRI and contrast enhanced ultrasound scans in people with chronic kidney
 disease and comparing the results.

ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06159439
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06159439 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nottingham and is currently Not yet recruiting. The study focuses on Chronic Kidney Diseases. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.